Research Careers Committee awards

Senior Cancer Research Fellowship

November 2025

Dissecting the molecular origins of ductular carcinomas in chronic tissue disease and regeneration

Dr Luke Boulter

University of Edinburgh

Explore the Senior Cancer Research Fellowship

Advanced Clinician Scientist Fellowship

This award is no longer accepting applications and will close following the May 2026 committee review.

November 2025

Cancer-selective CAR-T therapies for T cell malignancies

Dr Paul Maciocia

University College London

May 2025

Towards next-generation chimeric antigen receptor (CAR) therapies for acute leukaemia: a mechanistic dissection of therapeutic efficacy

Dr Sara Ghorashian

The UCL Great Ormond Street Institute of Child Health

(with support from Great Ormond Street Hospital Charity)

Career Development Fellowship

November 2025

Investigating the role of KRAS wildtype epithelial cells in pancreatic cancer initiation and progression

Dr Beatriz Salvador Barbero

Queen Mary University of London

Exploiting antibody-dependent cellular phagocytosis to treat hepatocellular carcinoma

Dr Felipe Galvez-Cancino

University of Oxford

Quantifying differentiation dynamics and dissecting their molecular regulation in myelodysplastic syndrome and acute myeloid leukemia

Dr Verena Korber

University of Oxford

Harnessing post-operative blood-brain barrier permeability for targeted nano therapies against aggressive brain tumours

Dr Thomas Kisby

University of Manchester

May 2025

Dedifferentiation and cancer: dissecting the molecular link between tissue injury and tumour initiation

Dr Miguel Bernabé-Rubio

University College London

Improving access to lung cancer early detection for individuals with severe mental illness and intellectual disability: reducing health inequity

Dr Lorna McWilliams

University of Manchester

Explore the Career Development Fellowship

Career Establishment Award

November 2025

Targeting cancer-associated fibroblast responses to metabolic stress to overcome the immunosuppressed tumour niche in hepatocellular carcinoma

Dr Jack Leslie

Newcastle University

May 2025

Exploiting anti-plasticity strategies to interfere with adaptive evolution in childhood neuroblastoma

Dr Alejandra Bruna

Institute of Cancer Research

Explore the Career Establishment Award

Clinician Scientist Fellowship

November 2024

Interrogating and targeting mechanisms by which cancer-associated fibroblasts limit radiotherapy responses in bladder cancer

Dr Anna Wilkins

Institute of Cancer Research

Chemotherapeutic Opportunities of METabolic heterogeneity in oesophageal adenocarcinoma (COMET)

Dr Stefan Antonowicz

Imperial College London

Funded by Cancer Research UK in partnership with Rosetrees Trust

Explore the Clinician Scientist Fellowship

Pre-doctoral Research Bursary

November 2025

Integration of epidemiology and spatial transcriptomics to study reproductive factors in renal cell carcinoma

Dr Katherine Wong

University of Oxford

(co-funded by Cancer Research UK and the Pathological Society)

PROSPECT-PLEURA: biomarker discovery to refine diagnosis and prognosis in histologically indeterminate pleural effusions

Dr Oliver Mann

Lancaster University

Incidence, survival and risk factors for early-onset oesophageal adenocarcinoma in England: a population-based cohort study using linked NHS data

Dr Mie Thu Ko

University of East Anglia

Exploring the B cell immune landscape in patients with cholangiocarcinoma receiving immunotherapy

Dr Richard Phillips

University of Birmingham

May 2025

The role and mechanism of highly variable genetic factors in cancer risk and prevention

Dr David Zocche

University of Oxford

Unravelling tumour-host metabolic interactions that underpin the efficacy of metformin in high-volume metastatic hormone sensitive prostate cancer

Dr Cameron Alexander

University of Manchester

Exploring the clonal landscape of oral potentially malignant disorders

Dr Grigorios Thermos

University of Liverpool

(co-funded by Cancer Research UK and the Pathological Society)

Evaluation of pre-operative ultra-high field magnetic resonance imaging for planning skull base tumour resection

Dr Frederick Renyard

University of Oxford

Explore the Pre-doctoral Research Bursary

Postdoctoral Research Bursary

This funding scheme is now closed.

November 2025

Targeting therapeutics to the leading edge of glioblastoma to prevent post-operative recurrence

Dr Mitchell Foster

University of Edinburgh

Replication stress relief mechanisms as dependencies in acute myeloid leukaemia

Dr Tumas Beinortas

University of Cambridge

Spatially resolved transcriptomic characterisation of adaptive cellular responses to neoadjuvant Encorafenib and Cetuximab in BRAF mutant colon cancer

Dr Mark White

Cancer Research UK Scotland Institute

May 2025

Distinct clonal alloimmune responses drive human graft versus leukaemia effect and graft versus host disease

Dr Callum Wright

Newcastle University

Clinical Trial Fellowship

November 2025

Advancing cancer precision prevention and early detection through trials in primary care

Dr Laura Heath

University of Oxford

Developing a future clinical trial oncologist in novel and precision therapies

Dr Amani Chowdhury

University College London

Explore the Clinical Trial Fellowship

Bridge to Academic Leadership

May 2025

Identifying novel targets for proximal colon cancer prevention and early detection

Dr Rhea Harewood

Imperial College London

Advanced causal modelling to improve understanding of late effects of radiotherapy in children and young adults

Dr Angela Davey

University of Manchester

Gaining traction in glioblastoma therapy: targetable mechanisms of force generation

Dr Alexander Loftus

University of Edinburgh

Refining HER2 diagnostics for an ultra-sensitive, objective assessment to guide therapy, inform resistance and monitor dynamic changes

Dr Rebecca Allsopp

University of Leicester

Targeting translation quality control machinery to enhance the efficiency of genotoxic drugs in colon cancer

Dr Susanta Chatterjee

Queen's University Belfast

Investigating cancer induced haematopoietic dysfunction: impact, mechanism and therapeutic potential

Dr Christopher Mapperley

Institute of Cancer Research

Explore the Bridge to Academic Leadership programme